{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:13:20Z","timestamp":1789866800576,"version":"4.0.1"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1097\/pas.0b013e3181da7687","type":"journal-article","created":{"date-parts":[[2010,4,21]],"date-time":"2010-04-21T02:30:10Z","timestamp":1271817010000},"page":"627-635","source":"Crossref","is-referenced-by-count":208,"title":["PAX8 Reliably Distinguishes Ovarian Serous Tumors From Malignant Mesothelioma"],"prefix":"10.1097","volume":"34","author":[{"given":"Anna R.","family":"Laury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Hornick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Perets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey F.","family":"Krane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Corson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Drapkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210131","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/01.pai.0000213144.70148.8e","article-title":"Expression of renal cell carcinoma antigen (RCC) in renal epithelial and nonrenal tumors: diagnostic Implications","volume":"15","author":"Bakshi","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R2-4-20210131","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1309\/8FCHQ3VPBWM7B5X9","article-title":"Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful","volume":"125","author":"Barnetson","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"R3-4-20210131","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1074\/mcp.R800013-MCP200","article-title":"A genecentric Human Protein Atlas for expression profiles based on antibodies","volume":"7","author":"Berglund","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"R4-4-20210131","doi-asserted-by":"crossref","first-page":"10602","DOI":"10.1158\/0008-5472.CAN-05-2240","article-title":"Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary","volume":"65","author":"Bonome","year":"2005","journal-title":"Cancer Res"},{"key":"R5-4-20210131","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R6-4-20210131","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1002\/cncr.11345","article-title":"Pathology and classification of ovarian tumors","volume":"97","author":"Chen","year":"2003","journal-title":"Cancer"},{"key":"R7-4-20210131","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0168-9525(01)02594-X","article-title":"Getting your Pax straight: Pax proteins in development and disease","volume":"18","author":"Chi","year":"2002","journal-title":"Trends Genet"},{"key":"R8-4-20210131","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.3800259","article-title":"Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma","volume":"18","author":"Chu","year":"2005","journal-title":"Mod Pathol"},{"key":"R9-4-20210131","first-page":"147","article-title":"Tumors of the Serosal Membranes","author":"Churg","year":"2006"},{"key":"R10-4-20210131","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000478-200604000-00006","article-title":"h-Caldesmon, a useful positive marker in the diagnosis of pleural malignant mesothelioma, epithelioid type","volume":"30","author":"Comin","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R11-4-20210131","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/PAS.0b013e318033e7a8","article-title":"h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary","volume":"31","author":"Comin","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R12-4-20210131","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molonc.2009.01.004","article-title":"Intercepting pelvic cancer in the distal fallopian tube: theories and realities","volume":"3","author":"Crum","year":"2009","journal-title":"Mol Oncol"},{"key":"R13-4-20210131","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res"},{"key":"R14-4-20210131","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1210\/jc.2002-021690","article-title":"Involvement of the PAX8\/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors","volume":"88","author":"Dwight","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-4-20210131","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cncy.20036","article-title":"Cytogenetics and fluorescence in situ hybridization as adjuncts to cytology in the diagnosis of malignant mesothelioma","volume":"117","author":"Factor","year":"2009","journal-title":"Cancer Cytopathol"},{"key":"R16-4-20210131","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/JTO.0b013e31815608d9","article-title":"Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center","volume":"2","author":"Flores","year":"2007","journal-title":"J Thorac Oncol"},{"key":"R17-4-20210131","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0002-9440(10)63902-8","article-title":"Genetic and biological subgroups of low-stage follicular thyroid cancer","volume":"162","author":"French","year":"2003","journal-title":"Am J Pathol"},{"key":"R18-4-20210131","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0046-8177(03)00177-1","article-title":"Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas","volume":"34","author":"Frierson","year":"2003","journal-title":"Hum Pathol"},{"key":"R19-4-20210131","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehensive analysis of HE4 expression in normal and malignant human tissues","volume":"19","author":"Galgano","year":"2006","journal-title":"Mod Pathol"},{"key":"R20-4-20210131","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.5858\/2003-127-1330-MEILNI","article-title":"Mammaglobin expression in lymph nodes is an important marker of metastatic breast carcinoma","volume":"127","author":"Han","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"R21-4-20210131","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"R22-4-20210131","doi-asserted-by":"crossref","first-page":"932371","DOI":"10.1155\/2010\/932371","article-title":"Ovarian cancer pathogenesis: a model in evolution","volume":"2010","author":"Karst","year":"2010","journal-title":"J Oncol"},{"key":"R23-4-20210131","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1371\/journal.pmed.0050232","article-title":"Ovarian carcinoma subtypes are different diseases: implications for biomarker studies","volume":"5","author":"Kobel","year":"2008","journal-title":"PLoS Med"},{"key":"R24-4-20210131","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1126\/science.289.5483.1357","article-title":"PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma","volume":"289","author":"Kroll","year":"2000","journal-title":"Science"},{"key":"R25-4-20210131","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New insights into the pathogenesis of serous ovarian cancer and its clinical impact","volume":"26","author":"Levanon","year":"2008","journal-title":"J Clin Oncol"},{"key":"R26-4-20210131","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/onc.2009.402","article-title":"Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis","volume":"29","author":"Levanon","year":"2010","journal-title":"Oncogene"},{"key":"R27-4-20210131","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2009.08.023","article-title":"Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma","volume":"115","author":"Liu","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R28-4-20210131","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ng0598-83","article-title":"PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis","volume":"19","author":"Macchia","year":"1998","journal-title":"Nat Genet"},{"key":"R29-4-20210131","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1210\/en.2006-1054","article-title":"Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy","volume":"148","author":"Mittag","year":"2007","journal-title":"Endocrinology"},{"key":"R30-4-20210131","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/modpathol.3800588","article-title":"Immunohistochemical detection of WT1 protein in a variety of cancer cells","volume":"19","author":"Nakatsuka","year":"2006","journal-title":"Mod Pathol"},{"key":"R31-4-20210131","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1681\/ASN.2006070739","article-title":"Pax2 and pax8 regulate branching morphogenesis and nephron differentiation in the developing kidney","volume":"18","author":"Narlis","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R32-4-20210131","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijsu.2008.04.004","article-title":"Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma","volume":"6","author":"Neragi-Miandoab","year":"2008","journal-title":"Int J Surg"},{"key":"R33-4-20210131","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1510\/icvts.2008.201509","article-title":"Chromosomal deletion in patients with malignant pleural mesothelioma","volume":"9","author":"Neragi-Miandoab","year":"2009","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R34-4-20210131","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1210\/jc.2002-021907","article-title":"RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma","volume":"88","author":"Nikiforova","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-4-20210131","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1002\/pmic.200500072","article-title":"Towards a human proteome atlas: high-throughput generation of mono-specific antibodies for tissue profiling","volume":"5","author":"Nilsson","year":"2005","journal-title":"Proteomics"},{"key":"R36-4-20210131","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R37-4-20210131","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/modpathol.3801002","article-title":"Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms","volume":"21","author":"Nonaka","year":"2008","journal-title":"Mod Pathol"},{"key":"R38-4-20210131","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00000478-200104000-00004","article-title":"h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors","volume":"25","author":"Nucci","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R39-4-20210131","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/00000478-199810000-00005","article-title":"Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas","volume":"22","author":"Ordonez","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R40-4-20210131","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/978-1-60327-492-0_20","article-title":"Epidemiology of ovarian cancer","volume":"472","author":"Permuth-Wey","year":"2009","journal-title":"Methods Mol Biol"},{"key":"R41-4-20210131","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1242\/dev.110.2.643","article-title":"Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland","volume":"110","author":"Plachov","year":"1990","journal-title":"Development"},{"key":"R42-4-20210131","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1242\/dev.116.3.611","article-title":"PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms' tumors","volume":"116","author":"Poleev","year":"1992","journal-title":"Development"},{"key":"R43-4-20210131","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/path.2440","article-title":"The human protein atlas\u2014a tool for pathology","volume":"216","author":"Ponten","year":"2008","journal-title":"J Pathol"},{"key":"R44-4-20210131","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0344-0338(00)80084-9","article-title":"Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas?","volume":"196","author":"Reis-Filho","year":"2000","journal-title":"Pathol Res Pract"},{"key":"R45-4-20210131","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.athoracsur.2007.06.066","article-title":"Malignant pleural mesothelioma: surgical management in 285 patients","volume":"85","author":"Schipper","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"R46-4-20210131","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/00000478-199611000-00004","article-title":"Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases","volume":"20","author":"Seidman","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R47-4-20210131","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R48-4-20210131","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am J Pathol"},{"key":"R49-4-20210131","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation","volume":"29","author":"Singer","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R50-4-20210131","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1097\/PAS.0b013e31816b1020","article-title":"Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract: evidence of related histogenesis?","volume":"32","author":"Tong","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R51-4-20210131","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/modpathol.2009.88","article-title":"Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study","volume":"22","author":"Tong","year":"2009","journal-title":"Mod Pathol"},{"key":"R52-4-20210131","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1074\/mcp.M500279-MCP200","article-title":"A human protein atlas for normal and cancer tissues based on antibody proteomics","volume":"4","author":"Uhlen","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"R53-4-20210131","first-page":"860","article-title":"Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer","volume":"56","author":"Watson","year":"1996","journal-title":"Cancer Res"},{"key":"R54-4-20210131","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J Clin Oncol"},{"key":"R55-4-20210131","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/PAS.0b013e3181b6bde3","article-title":"Tenascin-X is a novel diagnostic marker of malignant mesothelioma","volume":"33","author":"Yuan","year":"2009","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000478-201005000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:19:49Z","timestamp":1786040389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000478-201005000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e3181da7687","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}